Quantamental Technologies LLC Iovance Biotherapeutics, Inc. Transaction History

Quantamental Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$5.36 - $9.06 $138,330 - $233,820	25,808 Added 177.06%	40,384 $284,000
Q1 2023 May 15, 2023	BUY	$5.53 - $8.22 $80,605 - $119,814	14,576 New	14,576 $89,000
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $10,483 - $14,421	1,100 Added 7.47%	15,833 $152,000
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $93,996 - $270,055	14,733 New	14,733 $163,000
Q4 2019 Feb 14, 2020	SELL	$17.95 - $29.41 $104,163 - $170,666	-5,803 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$17.99 - $26.0 $104,395 - $150,878	5,803 New	5,803 $106,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.24B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.